These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7456117)

  • 1. Clinical observations on propranolol in acute myocardial infarction: hemodynamics and metabolism.
    Mueller HS
    Triangle; 1980; 19(1):27-33. PubMed ID: 7456117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetic characteristics of propranolol in patients with a history of acute myocardial infarct].
    Katrukha SP; Kalenikov EI; Zagrebin SV; Kukes VG
    Farmakol Toksikol; 1987; 50(3):87-9. PubMed ID: 3609287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous administration of propranolol in the acute period of myocardial infarct].
    Gratsianskiĭ NA; Karpov IuA; Evdokimov VV; Bunaeva VE
    Ter Arkh; 1980; 52(10):33-9. PubMed ID: 7444780
    [No Abstract]   [Full Text] [Related]  

  • 4. [The comparative studies of hemodynamic effects of verapamil and propranolol in patients with acute myocardial infarction (author's transl)].
    Ichikawa M; Saito S; Takahashi N; Tomobe K; Yamamoto M; Watanabe I; Komaki K; Tanigawa N; Ozawa Y; Hatano M
    Kokyu To Junkan; 1979 Oct; 27(10):1103-7. PubMed ID: 504821
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological intervention on ST segment elevation by surface mapping in acute myocardial infarction.
    Sathyamurthy I; Ramamohan TV; Kaul U; Khalilullah M; Gupta MP
    Indian Heart J; 1979; 31(4):220-8. PubMed ID: 385484
    [No Abstract]   [Full Text] [Related]  

  • 6. [Propranolol (Inderal) in acute myocardial infarct].
    Nielsen BL; Jorgensen FS; Clausen J; Felsby M; Roin J; Strange B
    Ugeskr Laeger; 1967 May; 129(21):689-96. PubMed ID: 4877646
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic reactions to the use of beta-adrenoblockaders in acute myocardial infarct].
    Golikov AP; Maĭorov NI; Vaniev SB; Orlov AI
    Vrach Delo; 1980 Nov; (11):33-5. PubMed ID: 6110282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with using obzidan in myocardial infarct].
    Kuznetsov GP; Gligan LI; Zil'berman ES; Gubanova TG; Fel'dman MS
    Klin Med (Mosk); 1984 Mar; 62(3):35-8. PubMed ID: 6716927
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of propranolol on mortality and morbidity after acute myocardial infarction.
    Abela GS; Mehta J; Conti CR
    J Fla Med Assoc; 1982 Jun; 69(6):453-7. PubMed ID: 7097220
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of obsidan on the content of catecholamines and renin in the blood in myocardial infarct].
    Simerzin VV
    Sov Med; 1988; (11):59-62. PubMed ID: 3070784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of obsidan in different hemodynamic variants of acute myocardial infarction].
    Netiazhenko VZ; Parkhomenko AN
    Vrach Delo; 1986 Jan; (1):12-5. PubMed ID: 3953032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of obsidan and labetalol on the course of myocardial infarction].
    Sirenko IuN; Mironova OV; Ivanova DK; Shkliar LV
    Vrach Delo; 1988 Jun; (6):20-3. PubMed ID: 3047990
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oral propranolol, intravenous mannitol and oxygen inhalation on ST segment mapping in acute myocardial infarction.
    Das BK; Ohri VC; Parashar SK; Tewari SC; Sindhi JC; Chatterji JC
    Indian Heart J; 1983; 35(2):106-10. PubMed ID: 6409801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of adrenergic beta receptor blockaders in myocardial infarct].
    Florkiewicz H; Rymar B; Przegaliński J; Markiewicz M
    Pol Tyg Lek; 1980 Jun; 35(23):853-5. PubMed ID: 6997844
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol in acute myocardial infarction. A multicentre trial.
    Lancet; 1966 Dec; 2(7479):1435-8. PubMed ID: 4163441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the oxygen transport function of the blood of patients with myocardial infarcts during treatment with obzidan].
    Iaremenko OB; Parkhomenko AN; Netiazhenko VZ
    Vrach Delo; 1985 Nov; (11):52-5. PubMed ID: 4082554
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of obzidan on cell membrane permeability in myocardial infarct patients].
    Parkhomenko AN; Netiazhenko VZ; Angelutsa PA
    Vrach Delo; 1985 Aug; (8):16-9. PubMed ID: 4072104
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol and enzyme levels.
    Slutsky A
    Circulation; 1979 Jan; 59(1):192-3. PubMed ID: 758115
    [No Abstract]   [Full Text] [Related]  

  • 19. Propranolol in acute myocardial infarction.
    Wenkart TR
    Med J Aust; 1979 Jun; 1(12):572. PubMed ID: 470741
    [No Abstract]   [Full Text] [Related]  

  • 20. Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
    Dickerson LM; Carek PJ
    J Fam Pract; 2001 Aug; 50(8):652. PubMed ID: 11509153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.